Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H26N2S.ClH |
Molecular Weight | 338.938 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN1C2=C(C=CC=C2)C3=C1C(C)(CCN(C)C)SCC3
InChI
InChIKey=FJJSKKBQSGDHQK-UHFFFAOYSA-N
InChI=1S/C18H26N2S.ClH/c1-5-20-16-9-7-6-8-14(16)15-10-13-21-18(2,17(15)20)11-12-19(3)4;/h6-9H,5,10-13H2,1-4H3;1H
Molecular Formula | C18H26N2S |
Molecular Weight | 302.477 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Tandamine was developed as a selective serotonin reuptake inhibitor for the treatment of depression. Tandamine participated in clinical trials in hospitalized depressed patients, where it showed that the well-tolerated drug could be of some benefit for retarded depressions. In addition, was found in human volunteers, that tandamine possessed significant anticholinergic activity, to reduce appetite and to produce sedation. However, this drug has never been marketed.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/334686
was administered in doses from 75 to 200 mg to a group of 20 hospitalized depressed patients.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:13:20 GMT 2023
by
admin
on
Fri Dec 15 15:13:20 GMT 2023
|
Record UNII |
7516K9UGUG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
65474
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110652
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
C152507
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
58167-78-5
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
42821-35-2
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
7516K9UGUG
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY | |||
|
305532
Created by
admin on Fri Dec 15 15:13:20 GMT 2023 , Edited by admin on Fri Dec 15 15:13:20 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |